MedTrace Logo

The Effect of Hypermobility Healthy Individuals

NCT04208022 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2020-02-10

No results posted yet for this study

Summary

Benign Joint Hypermobility Syndrome is a hereditary connective tissue problem characterized by the emergence of multiple musculoskeletal problems in hypermobile individuals without a systemic rheumatologic disease. Studies have shown that hypermobility may also affect lung function. Playing wind instruments requires tiring breathing activity. The effect of wind instrument on lung function and how it affects lung function is a highly controversial issue. Given the distribution and importance of collagen tissue in the body, multiple effects of hypermobility are inevitable. The aim of this study was to evaluate the presence of hypermobility in young healthy individuals; The aim of the study is to investigate the effects of hypermobility on the cardiovascular system and to provide training to the participants regarding the findings.The aim of this study is to investigate the relationship of hypermobility with respiratory functions in professional hypermobile musicians and to compare this relationship with healthy hypermobile individuals who are not engaged in music.

Conditions

  • Respiratory Problems

Interventions

OTHER

Respiratory evaluation

Hypermobility and Respiratory evaluation

Sponsors & Collaborators

  • Saglik Bilimleri Universitesi

    collaborator OTHER

  • Istanbul Kültür University

    lead OTHER

Principal Investigators

  • Esra Pehlivan, Asst.Prof.Dr · Saglik Bilimleri Universitesi

  • Gulsah Karaca, Researcher · Istanbul Kültür University

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-08-01
Primary Completion
2020-12-30
Completion
2020-12-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04208022 on ClinicalTrials.gov